BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lenti MV, Selinger CP. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions. Expert Rev Gastroenterol Hepatol 2017;11:215-26. [PMID: 28099821 DOI: 10.1080/17474124.2017.1284587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Bonaz B. Is-there a place for vagus nerve stimulation in inflammatory bowel diseases? Bioelectron Med 2018;4:4. [PMID: 32232080 DOI: 10.1186/s42234-018-0004-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
2 Lenti MV, Cococcia S, Ghorayeb J, Di Sabatino A, Selinger CP. Stigmatisation and resilience in inflammatory bowel disease. Intern Emerg Med 2020;15:211-23. [PMID: 31893346 DOI: 10.1007/s11739-019-02268-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
3 Lee S, Seow CH, Adhikari K, Metcalfe A. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications. Aliment Pharmacol Ther 2020;51:544-52. [DOI: 10.1111/apt.15596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
4 Bonaz B, Sinniger V, Pellissier S. The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol. 2017;8:1452. [PMID: 29163522 DOI: 10.3389/fimmu.2017.01452] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 19.0] [Reference Citation Analysis]
5 Wang L, Fan R, Zhang C, Hong L, Zhang T, Wang Z, Zhong J. Patients' Educational Program Could Improve Azathioprine Adherence in Crohn's Disease Maintenance Therapy. Gastroenterol Res Pract 2020;2020:6848293. [PMID: 32382270 DOI: 10.1155/2020/6848293] [Reference Citation Analysis]
6 Lasa J, Correa G, Fuxman C, Garbi L, Linares ME, Lubrano P, Rausch A, Toro M, Yantorno M, Zubiaurre I, Peyrin-Biroulet L, Olivera P. Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study. Gastroenterol Res Pract 2020;2020:4060648. [PMID: 32411197 DOI: 10.1155/2020/4060648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tomar SK, Kedia S, Singh N, Upadhyay AD, Kamat N, Bopanna S, Yadav DP, Goyal S, Jain S, Makharia G, Ahuja V. Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease. JGH Open 2019;3:302-9. [PMID: 31406923 DOI: 10.1002/jgh3.12160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
8 Singh S, Picardo S, Seow CH. Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or Obstetric. Clin Gastroenterol Hepatol 2020;18:1367-80. [PMID: 31712084 DOI: 10.1016/j.cgh.2019.11.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
9 Mărginean CO, Meliţ LE, Mocanu S, Mărginean MO. Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature. Medicine (Baltimore) 2017;96:e6329. [PMID: 28296755 DOI: 10.1097/MD.0000000000006329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
10 Cantoro L, Lenti MV, Monterubbianesi R, Cicala M, Giannarelli D, Papi C, Kohn A, Di Sabatino A. Early-onset versus late-onset Crohn's disease: An Italian cohort study. United European Gastroenterol J 2020;8:52-8. [PMID: 32213053 DOI: 10.1177/2050640619860661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Castillo G, Mack DR, Lalu MM, Singleton R, Fergusson DA, Stintzi A, Harrison M, Presseau J. Factors contributing to fidelity in a pilot trial of individualized resistant starches for pediatric inflammatory bowel disease: a fidelity study protocol. Pilot Feasibility Stud 2021;7:75. [PMID: 33741062 DOI: 10.1186/s40814-021-00815-1] [Reference Citation Analysis]
12 Yu M, Ye Z, Chen Y, Qin T, Kou J, Tian D, Xiao F. Questionnaire assessment helps the self-management of patients with inflammatory bowel disease during the outbreak of Coronavirus Disease 2019. Aging (Albany NY) 2020;12:12468-78. [PMID: 32628131 DOI: 10.18632/aging.103525] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Selinger C, Carbonell J, Kane J, Omer M, Ford AC. Acceptability of a 'treat to target' approach in inflammatory bowel disease to patients in clinical remission. Frontline Gastroenterol 2021;12:30-8. [PMID: 33493249 DOI: 10.1136/flgastro-2019-101366] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Refaie E, García Mateo S, Martínez Domínguez SJ, Gargallo-Puyuelo CJ, Lario Quilez L, Carrera-Lasfuentes P, Arroyo Villarino MT, Gomollón García F. Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease. Gastroenterol Hepatol 2021:S0210-5705(21)00154-0. [PMID: 34023473 DOI: 10.1016/j.gastrohep.2021.03.012] [Reference Citation Analysis]
15 Wang L, Fan R, Zhang C, Hong L, Zhang T, Chen Y, Liu K, Wang Z, Zhong J. Applying Machine Learning Models to Predict Medication Nonadherence in Crohn's Disease Maintenance Therapy. Patient Prefer Adherence. 2020;14:917-926. [PMID: 32581518 DOI: 10.2147/ppa.s253732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]